Status:

COMPLETED

Placenta, Fetal Liver, Sectional Ductus Venosus Volumes Examined by Three-dimensional Ultrasound in the Second Trimester

Lead Sponsor:

Sanliurfa Mehmet Akif Inan Education and Research Hospital

Conditions:

Gestational Diabetes

DUCTUS VENOSUS VOLUME

Eligibility:

FEMALE

18-45 years

Phase:

NA

Brief Summary

Investigators measured the placenta, fetal liver and ductus venosus volumes of pregnant women with GDM diagnosis and normal glycemic indices in the second trimester.Investigators aimed to correlate me...

Detailed Description

GDM screening may not always be possible with OGTT performed in limited weeks of gestation. In addition, mid-trimester ultrasound scanning is done in all pregnancies. Therefore, measurement of placent...

Eligibility Criteria

Inclusion

  • singleton pregnancy
  • diagnosed with GDM

Exclusion

  • multiple pregnancy
  • congenital anomalies
  • gestational hypertansion
  • preeclampsia

Key Trial Info

Start Date :

September 22 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 31 2022

Estimated Enrollment :

139 Patients enrolled

Trial Details

Trial ID

NCT06178250

Start Date

September 22 2021

End Date

July 31 2022

Last Update

December 20 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Nefise Nazlı YENIGUL

Bursa, Turkey (Türkiye), 16110

Placenta, Fetal Liver, Sectional Ductus Venosus Volumes Examined by Three-dimensional Ultrasound in the Second Trimester | DecenTrialz